Nivolumab
BMS
['cm577', 'prince,(-princes)', 'margaret', 'nivo', 'check,mate,577', 'gastroesophageal', 'nivolumab', 'checkmate 577', 'esophageal', 'pola']
a privilege on behalf of the study team to report exploratory biomarkers from cm577 at #wcgic2023 largest bm dataset in this setting ges can predict benefit dfs benefit across all mutations xrt priming effect on pdl1 shown for 1st time 
Director of Oncology Charles A. Sammons Cancer Center Baylor University Medical Center at #Dallas and Chief of Oncology NTX @BSWHealth